[Form 4] OneSpaWorld Holdings Limited Insider Trading Activity

Rhea-AI Filing Summary

Glenn Fusfield, a director of OneSpaWorld Holdings Ltd (OSW), reported a series of open-market sales of the issuer's common shares across three dates in August 2025. The filing shows he sold a total of 23,970 shares directly (1,147 on 08/14/2025, 9,237 on 08/15/2025, and 13,586 on 08/18/2025) at prices between $21.63 and $22.05. Separately, shares held by the Fusfield Family Irrevocable Trust were sold: 13,740 shares across the same dates at similar prices. After these transactions, Fusfield directly beneficially owns 202,353 shares and indirectly owns 6,060 shares via the trust. The report was signed by an attorney-in-fact on 08/18/2025.

Positive

• None.

Negative

• Director sold a substantial number of shares: 23,970 shares directly and 13,740 shares from the Fusfield Family Irrevocable Trust were disposed of in August 2025.
• Total insider disposals equal 37,710 shares, reducing direct holdings to 202,353 shares and indirect holdings to 6,060 shares.

Insights

Securities Analyst

TL;DR: Director executed multiple open-market sales totaling 23,970 direct shares; meaningful insider activity but no new holdings created.

The filing documents routine open-market dispositions by a director rather than grants or derivative transactions. Direct sales of 23,970 shares reduced his direct stake to 202,353 shares; related trust sales reduced indirect holdings to 6,060 shares. Prices ranged roughly from $21.63 to $22.09, indicating disposals at market prices across three settlement dates. There is no information in the filing about the purpose of the sales or any 10b5-1 plan. From a trading-impact perspective, the transactions disclose liquidity events by an insider but the filing contains no additional material corporate developments.

Corporate Governance Expert

TL;DR: Multiple insider sales over consecutive dates may attract investor attention; filing contains required disclosure and a trust relationship.

The report clarifies that Fusfield holds voting and dispositive power over shares owned by the Fusfield Family Irrevocable Trust while disclaiming beneficial ownership except for pecuniary interest. Combined insider disposals total 37,710 shares (23,970 direct, 13,740 trust), leaving 202,353 direct and 6,060 indirect shares. The signature is by an attorney-in-fact and the explanatory footnote about the trust is included. The filing does not state whether sales were pre-arranged under a Rule 10b5-1 plan; absence of that designation in the form means no affirmative defense is asserted here.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FUSFIELD GLENN

(Last) (First) (Middle)

770 SOUTH DIXIE HIGHWAY, SUITE 200

(Street)

CORAL GABLES FL 33146

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ONESPAWORLD HOLDINGS Ltd [ OSW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/14/2025		S		1,147	D	$22.03	225,176	D
Common Shares	08/15/2025		S		9,237	D	$21.63	215,939	D
Common Shares	08/18/2025		S		13,586	D	$22.05	202,353	D
Common Shares	08/14/2025		S		4,587	D	$21.81	15,213	I	By Fusfield Family Irrevocable Trust(1)
Common Shares	08/15/2025		S		4,625	D	$21.64	10,588	I	By Fusfield Family Irrevocable Trust(1)
Common Shares	08/18/2025		S		4,528	D	$22.09	6,060	I	By Fusfield Family Irrevocable Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person has voting and dispositive power over the securities held by Fusfield Family Irrevocable Trust ("Fusfield Trust"), and therefore may be deemed to indirectly beneficially own the securities held by Fusfield Trust. The reporting person disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

	/s/ Inga Fyodorova, as Attorney-in-Fact for Glenn Fusfield	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did OSW director Glenn Fusfield report in August 2025?

The Form 4 shows open-market sales on 08/14/2025, 08/15/2025, and 08/18/2025 totaling 37,710 shares (23,970 direct; 13,740 via the Fusfield Family Irrevocable Trust).

How many OSW shares does Glenn Fusfield beneficially own after the reported sales?

Following the transactions, Fusfield directly owns 202,353 shares and indirectly owns 6,060 shares through the Fusfield Family Irrevocable Trust.

At what prices were the OSW shares sold by the reporting person?

Reported sale prices ranged from $21.63 to $22.09 across the three reporting dates.

Does the Form 4 state the sales were made under a Rule 10b5-1 trading plan?

No. The filing does not indicate that the transactions were made pursuant to a 10b5-1(c) plan or assert the affirmative defense.

Who signed the Form 4 for Glenn Fusfield?

The Form 4 was signed on behalf of Glenn Fusfield by Inga Fyodorova, as Attorney-in-Fact on 08/18/2025.